Delivery Order SPE2DB22D1103-SPE2DB25FH3M5
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for Carvedilol ER 20 mg capsules (30-count) valued at $10,541.75. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) with a ceiling value of $1,606.87. This is a firm fixed-price delivery order issued under a non-competitive set-aside basis. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This delivery order is a child contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $23,482.35 for Carvedilol ER 10 mg capsules (30-count packaging) on August 26, 2025, with an ultimate completion date of August 27, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $2,537.02 to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on June 16, 2025, with completion scheduled for June 17, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award based on capability demonstration. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $5,926.63 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be conducted at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) with a ceiling value of $2,756.79 and an ultimate completion date of July 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing contract vehicle. The performance location is the company's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 80 mg capsules (30-count units) valued at $2,118.65. This competitive, non-set-aside award, issued on September 16, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 17, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a ceiling value of $1,886.17. This competitive award, which carries no set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The pharmaceutical supply is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packages) with a ceiling value of $5,976.74. This is a firm fixed price delivery order with an ultimate completion date of June 20, 2025, and represents a non-set-aside competitive award. The contractor's place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,963.74 on June 3, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packages). This competitively awarded, firm fixed-price contract is non-set-aside and carries an ultimate completion date of June 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH3M5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count packaging) valued at $2,663.43, with completion targeted for September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, supplying an extensive portfolio of pharmaceuticals and medical supplies to support military and veteran healthcare systems. This delivery order falls within AmerisourceBergen's comprehensive $999.999 billion IDC with DLA Troop Support Medical (designated SPE2DX), which extends through December 2026 and enables the company to supply a global range of pharmaceutical products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award demonstrates AmerisourceBergen's capability to fulfill federal medical supply requirements through open competition, consistent with its track record of delivering diverse pharmaceutical products ranging from specialty medications to generic drugs and medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/26/25 |